Growth Metrics

Biohaven (BHVN) Consolidated Net Income (2021 - 2026)

Biohaven has reported Consolidated Net Income over the past 6 years, most recently at -$130.5 million for Q1 2026.

  • Quarterly results put Consolidated Net Income at -$130.5 million for Q1 2026, up 41.12% from a year ago — trailing twelve months through Mar 2026 was -$647.7 million (up 27.11% YoY), and the annual figure for FY2025 was -$738.8 million, up 12.71%.
  • Consolidated Net Income reached -$130.5 million in Q1 2026 per BHVN's latest filing, up from -$145.6 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$68.9 million in Q3 2022 and bottomed at -$319.8 million in Q2 2024.
  • Median Consolidated Net Income over the past 5 years was -$160.3 million (2024), compared with a mean of -$158.5 million.
  • The largest annual shift saw Consolidated Net Income crashed 287.59% in 2022 before it soared 55.56% in 2023.
  • Over 5 years, Consolidated Net Income stood at -$201.1 million in 2022, then increased by 28.02% to -$144.8 million in 2023, then dropped by 29.07% to -$186.8 million in 2024, then rose by 22.1% to -$145.6 million in 2025, then rose by 10.32% to -$130.5 million in 2026.
  • Business Quant data shows Consolidated Net Income for BHVN at -$130.5 million in Q1 2026, -$145.6 million in Q4 2025, and -$173.4 million in Q3 2025.